Cite
HARVARD Citation
Casertano, S. et al. (2020). Ocrelizumab in a case of refractory chronic inflammatory demyelinating polyneuropathy with anti‐rituximab antibodies. European journal of neurology. pp. 2673-2675. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Casertano, S. et al. (2020). Ocrelizumab in a case of refractory chronic inflammatory demyelinating polyneuropathy with anti‐rituximab antibodies. European journal of neurology. pp. 2673-2675. [Online].